CRVS Stock Analysis: Buy, Sell, or Hold?
CRVS - Corvus Pharmaceuticals, Inc.
$21.26
0.28 (1.33%)
▲
5d:
-3.71%
30d:
+190.44%
90d:
+164.43%
BUY
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 24, 2026
Smart Money Accumulation
CRVS is down 3.4% this week, but smart money is accumulating calls. Top strike: $25 2026-04-17 with 1,068 OI. Call ratio: 67% View Scanner →
Strength: 3.3/10
Get Alerted When CRVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CRVS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CRVS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CRVS is currently trading at $21.26, which is considered extended relative to its 30-day fair value range of $6.00 to $20.98.
Technical Outlook: Technically, CRVS is in a uptrend. Immediate support is located at $19.53, while resistance sits at $26.95.
Market Sentiment: CRVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.33 (+58.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRVS is in a uptrend. Immediate support is located at $19.53, while resistance sits at $26.95.
Market Sentiment: CRVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.33 (+58.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$6.00 -
$20.98
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
Protect Your Profits
CRVS is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 58.9% below Wall St target ($33.33)
Fair Price Analysis
30-Day Fair Range
$6.00 -
$20.98
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$19.53
Resistance Level
$26.95
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-34.97
Wall Street Target
$33.33
(+58.9%)
Last updated: February 03, 2026 1:39 PM ET
Data refreshes hourly during market hours. Next update: 2:39 PM
Data refreshes hourly during market hours. Next update: 2:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 60 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$75 | 54 HOLD |
Advanced CRVS Option Strategies
Professional options setups generated by AI based on today's CRVS price and gamma walls.
